CORDIS · 101160079 · HORIZON
BRIDGING-RD BRIDGing the research and INnovation Gap for Rare Diseases in Europe by upgrading excellence of IMGGE
Coordinator: INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS)
There are over 330 million people living on the planet affected by one of over 6,000 identified genetic rare diseases (RD). They urgently need timely diagnosis and development of specific treatments. Although Europe leads the way in RD research, there is a clear gap in research and innovation (R&I) between countries. To bridge this gap, networking and knowledge sharing between IMGGE (Institute of Molecular Genetics and Genetic Engineering, Serbia) and 3 world-class counterparts at EU level - KI (Karolinska Institute, Sweden), CNAG (National Center for Genomic Analysis, Spain) and UAM (Autonom…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
The project runs over approximately 3 years from 2024-10-01 to 2027-09-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from RS
see all →- CROSS-REIS — CROSS-disciplinary network for research excellence in Regenerative Economy Innovation eco-Systems101136834 · HORIZON · €4.4M
- EINSTEIN — EXCELLENCE INITIATIVE FOR NUTRIFOOD-BASED THERANOSTICS FOR HEALTHY EUROPEAN SOCIETY101136377 · HORIZON · €3.9M
- SENSEIVER — Low-cost and energy-efficient LTCC sensor/IR-UWB transceiver solutions for sustainable healthy environment289481 · FP7 · €3.0M
- INNOSENSE — Reinforcement of BioSense Center – ICT for Sustainability and Eco-Innovation316191 · FP7 · €2.6M
- HEROMAT — PROTECTION OF CULTURAL HERITAGE OBJECTS WITH MULTIFUNCTIONAL ADVANCED MATERIALS282992 · FP7 · €2.6M
- HIP-2D-QM — HIDDEN PHASES IN 2D-QUANTUM MATERIALS101185375 · HORIZON · €2.5M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2023-ACCESS-02.
- Who coordinates the project?
- The project is coordinated by INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS).
- What is the project timeline?
- The project runs from 2024-10-01 to 2027-09-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101160079.